Stay updated on Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial page.

Latest updates to the Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedThe study record now shows termination of GEN1046 development with a sponsor note that the decision was not due to safety concerns; recruitment site details and statuses have been updated, including removal or alteration of certain locations.SummaryDifference0.4%

- Check11 days agoChange DetectedIsrael study locations were updated: Tel Litwinsky, Israel, 52621 was removed and Qiryat Krinitzi, Israel, 52621 was added.SummaryDifference0.1%

- Check18 days agoChange DetectedAdded NIH grant/contract entries for 2018 and 2023, and updated the page revision to v3.6.6 (replacing v3.6.5).SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedResults status on the study page was updated to 'Results Posted' with new and clarified safety and efficacy outcomes for Dose Escalation and Expansion cohorts (DLT, treatment-emergent AEs, ORR, DCR, DoR, PFS, OS) and related data descriptors. Study documents and data timing details (cycle lengths) were added, along with links to the Study Protocol and Statistical Analysis Plan PDFs.SummaryDifference2%

- Check53 days agoChange DetectedDifference0.0%

- Check74 days agoChange DetectedThe page revision has been updated from v3.6.2 to v3.6.3. This indicates a platform-level update to the page, likely involving minor fixes or improvements without changing the study details.SummaryDifference0.0%

Stay in the know with updates to Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial page.